Close Menu
Home » The Scan » Getting Closer

Getting Closer

Jul 21, 2009

Jeremy Grushcow at The Cross-Border Biotech Blog points to the KRAS mutation genetic test to identify patients who won't respond to Erbitux or Vectibix as "exactly how personalized medicine and comparative effectiveness can interact to benefit patients, pharma companies and payors." Grushcow says payors benefit by the elimination of unneces

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Commission's First Meeting

At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.

More Scrutiny

The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.

Web of Neutrophil DNA

Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.

Science Explores Method to Infer Genotype-by-Environment Interactions

In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.